AAAAAA
Results:
1-17
|
Results: 17
Authors:
EISENHAUER E
BACON M
WALSH W
MCDANIEL C
CANETTA R
ONETTO N
ZEE B
Citation: E. Eisenhauer et al., LONG-TERM SURVIVORS FROM A EUROPEAN-CANADIAN TRIAL OF PACLITAXEL IN PLATINUM-PRETREATED OVARIAN-CANCER (OVCA), European journal of cancer, 33, 1997, pp. 532-532
Authors:
TULPULE A
RARICK MU
KOLITZ J
BERNSTEIN J
HARVEYBUCHANAN L
ESPINA BM
TRADER G
MUKWAYA G
ONETTO N
GILL PS
LEVINE AM
Citation: A. Tulpule et al., DAUNOXOME IN THE TREATMENT OF RELAPSED REFRACTORY LOW-GRADE AND INTERMEDIATE GRADE NON-HODGKINS-LYMPHOMA (NHL)/, Blood, 90(10), 1997, pp. 846-846
Authors:
SWENERTON K
HOSKINS P
STUART G
BATIST G
PIKE J
ONETTO N
FISHER B
EISENHAUER E
Citation: K. Swenerton et al., A PHASE-I STUDY OF BIWEEKLY PACLITAXEL CISPLATIN AS INITIAL THERAPY FOR ADVANCED OVARIAN-CANCER - A STUDY OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP/, Annals of oncology, 7(10), 1996, pp. 1077-1079
Authors:
GELMON KA
OREILLY SE
TOLCHER AW
CAMPBELL C
BRYCE C
RAGAZ J
COPPIN C
PLENDERLEITH IH
AYERS D
MCDERMOTT B
NAKASHIMA L
HEALEY D
ONETTO N
Citation: Ka. Gelmon et al., PHASE I II TRIAL OF BIWEEKLY PACLITAXEL AND CISPLATIN IN THE TREATMENT OF METASTATIC BREAST-CANCER/, Journal of clinical oncology, 14(4), 1996, pp. 1185-1191
Authors:
SEIDMAN AD
PORTENOY R
YAO TJ
LEPORE J
MONT EK
KORTMANSKY J
ONETTO N
REN L
GRECHKO J
BELTANGADY M
USAKEWICZ J
SOUHRADA M
HOUSTON C
MCCABE M
SALVAGGIO R
THALER H
NORTON L
Citation: Ad. Seidman et al., QUALITY-OF-LIFE IN PHASE-II TRIALS - A STUDY OF METHODOLOGY AND PREDICTIVE VALUE IN PATIENTS WITH ADVANCED BREAST-CANCER TREATED WITH PACLITAXEL PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR, Journal of the National Cancer Institute, 87(17), 1995, pp. 1316-1322
Authors:
ABRAMS JS
VENA DA
BALTZ J
ADAMS J
MONTELLO M
CHRISTIAN M
ONETTO N
DESMONDHELLMANN S
CANETTA R
FRIEDMAN MA
ARBUCK SG
Citation: Js. Abrams et al., PACLITAXEL ACTIVITY IN HEAVILY PRETREATED BREAST-CANCER - A NATIONAL-CANCER-INSTITUTE TREATMENT REFERRAL CENTER TRIAL, Journal of clinical oncology, 13(8), 1995, pp. 2056-2065
Authors:
SEIDMAN AD
REICHMAN BS
CROWN JPA
YAO TJ
CURRIE V
HAKES TB
HUDIS CA
GILEWSKI TA
BASELGA J
FORSYTHE P
LEPORE J
MARKS L
FAIN K
SOUHRADA M
ONETTO N
ARBUCK S
NORTON L
Citation: Ad. Seidman et al., PACLITAXEL AS 2ND AND SUBSEQUENT THERAPY FOR METASTATIC BREAST-CANCER- ACTIVITY INDEPENDENT OF PRIOR ANTHRACYCLINE RESPONSE, Journal of clinical oncology, 13(5), 1995, pp. 1152-1159
Authors:
DIERAS V
MARTY M
TUBIANA N
CORETTE L
MORVAN F
SERIN D
MIGNOT L
CHAZARD M
GARET F
ONETTO N
HELLMANN S
POUILLART P
Citation: V. Dieras et al., PHASE-II RANDOMIZED STUDY OF PACLITAXEL VERSUS MITOMYCIN IN ADVANCED BREAST-CANCER, Seminars in oncology, 22(4), 1995, pp. 33-39
Authors:
CANETTA R
ONETTO N
DESMONDHELLMANN S
CARTER SK
Citation: R. Canetta et al., FUTURE-DIRECTIONS FOR PACLITAXEL (TAXOL(R)) IN GYNECOLOGIC MALIGNANCIES, International journal of gynecological cancer, 4, 1994, pp. 23-26
Authors:
EISENHAUER EA
HUININK WWT
SWENERTON KD
GIANNI L
MYLES J
VANDERBURG MEL
KERR I
VERMORKEN JB
BUSER K
COLOMBO N
BACON M
SANTABARBARA P
ONETTO N
WINOGRAD B
CANETTA R
Citation: Ea. Eisenhauer et al., EUROPEAN-CANADIAN RANDOMIZED TRIAL OF PACLITAXEL IN RELAPSED OVARIAN-CANCER - HIGH-DOSE VERSUS LOW-DOSE AND LONG VERSUS SHORT INFUSION, Journal of clinical oncology, 12(12), 1994, pp. 2654-2666
Authors:
SEIDMAN AD
NORTON L
REICHMAN BS
CROWN JPA
YAO TJ
HAKES TB
LEBWOHL DE
GILEWSKI TA
HUDIS CA
SURBONE A
CURRIE V
KLECKER R
JAMISDOW C
COLLINS J
MARKS L
QUINLIVAN S
BERKERY R
CANETTA R
ONETTO N
ARBUCK S
Citation: Ad. Seidman et al., TAXOL (PACLITAXEL) PLUS RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN THE TREATMENT OF METASTATIC BREAST-CANCER, Oncology, 51, 1994, pp. 33-39
Authors:
HELLMANN S
QUIST M
BASLER G
BURROUGHS J
FLORCZYK A
ONETTO N
CANETTA R
Citation: S. Hellmann et al., HEMATOLOGICAL SAFETY PROFILE OF TAXOL(R) (PACLITAXEL) IN PATIENTS WITH METASTATIC BREAST-CANCER (MBC) AND OVARIAN-CANCER (OV), Blood, 84(10), 1994, pp. 10000590-10000590
Authors:
RUSTHOVEN JJ
EISENHAUER E
MAZURKA J
HIRTE H
OCONNELL G
MULDAL A
LU HX
ONETTO N
SWENERTON K
JEFFREY J
Citation: Jj. Rusthoven et al., PHASE-I CLINICAL-TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-3 COMBINED WITH CARBOPLATIN IN THE TREATMENT OF PATIENTS WITH RECURRENT OVARIAN-CARCINOMA, Journal of the National Cancer Institute, 85(10), 1993, pp. 823-825
Authors:
PEEREBOOM DM
DONEHOWER RC
EISENHAUER EA
MCGUIRE WP
ONETTO N
HUBBARD JL
PICCART M
GIANNI L
ROWINSKY EK
Citation: Dm. Peereboom et al., SUCCESSFUL RETREATMENT WITH TAXOL AFTER MAJOR HYPERSENSITIVITY REACTIONS, Journal of clinical oncology, 11(5), 1993, pp. 885-890
Authors:
TRIMBLE EL
ADAMS JD
VENA D
HAWKINS MJ
FRIEDMAN MA
FISHERMAN JS
CHRISTIAN MC
CANETTA R
ONETTO N
HAYN R
ARBUCK SG
Citation: El. Trimble et al., PACLITAXEL FOR PLATINUM-REFRACTORY OVARIAN-CANCER - RESULTS FROM THE FIRST 1,000 PATIENTS REGISTERED TO NATIONAL-CANCER-INSTITUTE TREATMENT-REFERRAL-CENTER-9103, Journal of clinical oncology, 11(12), 1993, pp. 2405-2410
Authors:
OREILLY SE
GELMON KA
ONETTO N
PARENTE J
RUBINGER M
PAGE RA
PLENDERLEITH IH
Citation: Se. Oreilly et al., PHASE-I TRIAL OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR DERIVED FROM YEAST IN PATIENTS WITH BREAST-CANCER RECEIVING CYCLOPHOSPHAMIDE, DOXORUBICIN, AND FLUOROURACIL, Journal of clinical oncology, 11(12), 1993, pp. 2411-2416
Authors:
ARBUCK SG
CANETTA R
ONETTO N
CHRISTIAN MC
Citation: Sg. Arbuck et al., CURRENT DOSAGE AND SCHEDULE ISSUES IN THE DEVELOPMENT OF PACLITAXEL (TAXOL(R)), Seminars in oncology, 20(4), 1993, pp. 31-39
Risultati:
1-17
|